Cairo – Mubasher: October Pharma recorded a surge of 402% in net profits to EGP 40.59 million during the first quarter (Q1) of 2021, compared to EGP 8.08 million in the same quarter a year ago.
Revenues increased by 38% to total EGP 165.83 million in Q1-21 from EGP 120.23 million in Q1-20, according to a bourse disclosure on Sunday.
The company’s earnings per share stood at EGP 6.77 in the first three months of 2021, compared to EGP 1.35 in the same period last year.
October Pharma earlier registered an annual growth of 161% in net profits to EGP 88.26 million in 2020.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
